Literature DB >> 17707346

Modulation of early growth response gene 1 and interleukin-8 expression by ribotoxin deoxynivalenol (vomitoxin) via ERK1/2 in human epithelial intestine 407 cells.

Yuseok Moon1, Hyun Yang, Soo Hyung Lee.   

Abstract

Epithelium senses external toxic insults transmit the sentinel signals into the cells to reprogram a broad range of mucosal responses like epithelial inflammatory diseases. The purpose of this study was to test the hypothesis that ribotoxin DON evokes the epithelial sentinel signals which contributes to the pro-inflammatory cytokine interleukin-8 in human epithelial cells. Treatment with DON elevated interleukin-8 production in the human epithelial intestine 407 cells. Particularly, ribotoxin DON markedly elevated the phosphorylated extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) mitogen-activated protein kinase (MAPK) which mediated DON-induced interleukin-8 (IL-8) production. DON-activated ERK1/2 also mediated the production of early growth response gene 1 (EGR-1) in the epithelial cell line and EGR-1 had the positive regulatory effect on the interleukin-8 production in the human epithelial cells. Taken all, DON-activated MAPK sentinel signals of the epithelial cells which promoted interleukin-8 production and its positive modulator EGR-1. These findings will provide insight into the possible mechanism associated with the early epithelial inflammation by ribotoxic insults.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17707346     DOI: 10.1016/j.bbrc.2007.07.168

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  The functional role of reactive stroma in benign prostatic hyperplasia.

Authors:  Isaiah G Schauer; David R Rowley
Journal:  Differentiation       Date:  2011-06-12       Impact factor: 3.880

2.  Targeted knockdown of EGR-1 inhibits IL-8 production and IL-8-mediated invasion of prostate cancer cells through suppressing EGR-1/NF-kappaB synergy.

Authors:  Jiajia Ma; Zijia Ren; Yang Ma; Lu Xu; Ying Zhao; Chaogu Zheng; Yinghui Fang; Ting Xue; Baolin Sun; Weihua Xiao
Journal:  J Biol Chem       Date:  2009-10-16       Impact factor: 5.157

3.  Induction of MAPK-dependent transcription factors by deoxynivalenol in human cell lines.

Authors:  Maximilian Casteel; Carina Nielsen; Andrea Didier; Richard Dietrich; Erwin Märtlbauer
Journal:  Mycotoxin Res       Date:  2010-01-12       Impact factor: 3.833

4.  Keratinocyte-derived chemokine induces prostate epithelial hyperplasia and reactive stroma in a novel transgenic mouse model.

Authors:  Isaiah G Schauer; Steven J Ressler; David R Rowley
Journal:  Prostate       Date:  2009-03-01       Impact factor: 4.104

Review 5.  Mucosal injuries due to ribosome-inactivating stress and the compensatory responses of the intestinal epithelial barrier.

Authors:  Yuseok Moon
Journal:  Toxins (Basel)       Date:  2011-10-20       Impact factor: 4.546

Review 6.  Effect of deoxynivalenol and other Type B trichothecenes on the intestine: a review.

Authors:  Philippe Pinton; Isabelle P Oswald
Journal:  Toxins (Basel)       Date:  2014-05-21       Impact factor: 4.546

Review 7.  From the gut to the brain: journey and pathophysiological effects of the food-associated trichothecene mycotoxin deoxynivalenol.

Authors:  Marc Maresca
Journal:  Toxins (Basel)       Date:  2013-04-23       Impact factor: 4.546

Review 8.  Effects of Mycotoxins on mucosal microbial infection and related pathogenesis.

Authors:  Seong-Hwan Park; Dongwook Kim; Juil Kim; Yuseok Moon
Journal:  Toxins (Basel)       Date:  2015-10-30       Impact factor: 4.546

Review 9.  Ribosomal alteration-derived signals for cytokine induction in mucosal and systemic inflammation: noncanonical pathways by ribosomal inactivation.

Authors:  Yuseok Moon
Journal:  Mediators Inflamm       Date:  2014-01-02       Impact factor: 4.711

10.  Interference with mutagenic aflatoxin B1-induced checkpoints through antagonistic action of ochratoxin A in intestinal cancer cells: a molecular explanation on potential risk of crosstalk between carcinogens.

Authors:  Juil Kim; Seong-Hwan Park; Kee Hun Do; Dongwook Kim; Yuseok Moon
Journal:  Oncotarget       Date:  2016-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.